Read an important notice regarding the data security incident McKesson reported on August 28, 2026. Read more.
USOR 23253 - STAR Clinical Study to Further Evaluate Trametinib with rare BRAF V600E or met Solid Tumors
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors (CDRB436IIC01)
Disease Types: Solid Tumor, STAR: Selected Trials Available for Accelerated Four Week Rollout
Available at: Arlington Heights, Chicago, Niles